Established over 100 years ago, Alfreton Park Veterinary Hospital is based in a purpose-built clinic; one of four International Society of Feline Medicine (ISFM) recognised Cat Friendly Practices in Derbyshire.
Dr Nick Pine MA VetMB MRCVS has been at Alfreton Park since 1999 and has become a Medivet Branch Partner following the acquisition, together with his colleague Dr Matt Ingram CertSAS MRCVS. He said: "We are excited about joining the Medivet Partnership. It will help us to continue to develop what is an already successful, trusted and highly respected local practice and enable us to offer even more opportunities for our people."
Medivet Chief Executive Officer Dr Arnold Levy, said: "Alfreton Park is an impressive practice with a great team and we are delighted to welcome them to Medivet. Our model is focused on adding value to every practice that joins our partnership, and we look forward to working with Nick and Matt to build an even brighter future for the practice, its clients and patients."
According to a report in the Daily Mail, Worcester vet David Denny MRCVS accidentally euthanised a Jack Russell in the presence of its owner, who believed he was giving the animal antibiotics.
Mr Denny told VetSurgeon.org that it had been the result of a dreadful misunderstanding between himself and his secretary, for which he had apologised, but that he couldn't say much more because the VDS had advised him not to talk to the media.
The dog, called Gunner, was 14 years old; old enough that alarm bells obviously didn't go off when it was presented to Mr Denny for euthanasia (or so he thought).
The story does serve as a reminder of the importance of communicating with absolute clarity, both written and oral, when performing euthanasia. In this case, the Daily Mail reports that Mr Denny asked the client: "if Gunner had had enough". Under any other circumstances, that would seem a sensitive comment to make. In this case, though, the owner thought he meant the dog had had enough of its cough.
The VetCompass programme studied 10,313 English Cocker Spaniels from an overall sample of 336,865 UK dogs of all breeds under first opinion veterinary care during 2016.
English Cocker Spaniels made up 3.1% of all dogs, showing ongoing high popularity of this breed as a UK companion animal.
The most common disease was periodontal disease, diagnosed in 20.97% of English Cocker Spaniels each year.
In second place was otitis externa (10.09%), followed by obesity/overweight (9.88%), anal sac impaction (8.07%), diarrhoea (4.87%), and aggression (4.01%).
The order of these top disorders in English Cocker Spaniels was similar to those previously reported in dogs overall; however, the frequency of each disorder was generally higher in English Cocker Spaniels than the general dog population, possibly because several of these conditions are related to the longer ears and looser skin on English Cocker Spaniels.
Researchers say these results suggests that English Cocker Spaniels can be considered a typical dog in many respects, but with higher risk of some disorders related to their specific body shape.
Aggression was found to be relatively common in English Cocker Spaniels, although the frequency differed depending on the sex and coat colour of the dogs: aggression was more common in males than females, and in single-coloured than multi-coloured dogs.
The risk of aggression also varied widely between the four most common single-coloured coat colours: golden-coloured dogs showed the highest frequency of aggression (12.08%), followed by red (6.52%), black (6.29%), and liver (4.33%).
Additional findings include:
Karolina Engdahl, Epidemiologist at the Swedish University of Agricultural Sciences and lead author of the paper, said: “English Cocker Spaniels are popular family dogs and can make fantastic pets.
"However, we found that aggression was relatively common in the breed, especially in golden-coloured dogs.
"This highlights the importance of focusing good breeding on behavioural as well as physical health, and that behavioural-related problems should be a key area for veterinary-owner discussions.”
Dan O’Neill, Associate Professor in Companion Animal Epidemiology at the RVC, co-author of the paper, said: “Everyone who loves dogs just wants their animals to live long and happy lives.
"This study provides the data to help owners to understand that preventing dental, ear, weight and anal sac problems can go a long way to helping English Cocker Spaniels to enjoy a better life.
"It really can be that simple.”
Kruuse has announced that it has become the exclusive UK and Ireland distributor for Pulse Veterinary Technologies LLC shockwave systems, including the Versatron, Versatron 4paws and Equitron.
Shockwave therapy, otherwise known as extracorporeal shock wave therapy (ESWT), uses a high-energy sound wave that rapidly increases pressure as it travels through tissue. It is a non-invasive modality used to stimulate healing particularly in ligament, tendon or boney structures.
Andrew Groom, Managing Director, Kruuse UK Ltd said: "This agreement widens the Kruuse equine and small animal capital equipment profile within the UK and Ireland; increasing the range of technologies available to the veterinary practitioner , whilst providing aftercare support of existing shockwave users".
Eric Goorno , Chief Executive Officer, Pulse Veterinary Technologies LLC said: "This exciting partnership will further enhance our presence within the veterinary industry and allow Kruuse UK to bring leading edge technology to its customers, building upon its strong relationships within veterinary practices".
The statistic came to light as a result of Ceva's Mercury Challenge1, in which veterinary practices from around Europe took blood pressure readings from over 10,000 cats over seven years old, 4000 of which were from the UK.
The Challenge results, which were recently presented at Ceva Cat Expertise 2021 by the international feline medicine specialist, Dr Andy Sparkes, showed that more than 40% of cats enrolled in the Mercury Challenge were hypertensive, with a blood pressure about 30% higher than the blood pressure value found in healthy cats.
Ceva says this high percentage suggests that feline hypertension may be even more common than suspected, especially in the ageing cat population, with the mean age of hypertensive cats found to be 13 years old in the Challenge.
The study also found that up to one in three cats had both hypertension and chronic kidney disease (CKD). Feline hypertension is also associated with hyperthyroidism.
Jodie Tanner, veterinary surgeon at Lime Tree Vets in Staffordshire who participated in the Mercury Challenge said: “We were surprised by how many of the cats whose blood pressure we measured as part of the Mercury Challenge were actually hypertensive and were taken aback at the number of hypertensive cats which lacked clinical signs or target organ damage.
"These hypertensive cats would have previously gone undetected prior to us screening our older patients and they would probably have only presented when they had advanced target organ damage, such as blindness.
“Measuring blood pressure in cats is now incorporated into our bespoke preventative health care plan – The Pet Plus Membership – and our ‘Gold Plan’ is tailored to our patients over eight years of age.
"Included in the Gold Plan are twice yearly blood pressure checks, so we can pick up hypertension cases as early as possible, and the plan also includes twice yearly urine screens and yearly blood screens to pick up other common diseases seen in older cats such as hyperthyroidism and CKD.”
Ceva has a range of resources available to support veterinary practices, including those that want to set up vet nurse blood pressure clinics. There's a digital hypertension tool kit available by registering at www.easethepressure.co.uk, where you will also find information on the Hypertension CPD Hub, an Ease the Pressure pack containing resources to support vet practices, owner communications materials and information about Ceva’s online Hypertension Ambassador CPD course. A vet practice social media pack is also available.
For further information, visit www.easethepressure.co.uk or contact your local Ceva territory manager.
Reference
Royal Veterinary College research, published in the journal PLOS ONE, has revealed that 1 in 4 cases of Diabetes Mellitus in domestic cats are caused by excess secretion of pituitary growth hormone.
According to the researchers, this is much more common than previously thought. Furthermore, they say that cats with this condition are easily misdiagnosed as having primary (type 2) diabetes mellitus but do not respond to the standard treatment to that condition, resulting in increased morbidity and ultimately leading to euthanasia on welfare grounds.
Researchers collected data between 2003 and 2011 on cats treated at vet practices across the UK, to estimate the prevalence of hypersomatotropism or acromegaly in the largest cohort of diabetic cats to date and look how easy this is to recognise.
Findings revealed that the presence of Diabetes Mellitus in 1 in 4 domestic cats can be explained by hypersomatotropism, which is caused by a pituitary benign tumour and can be effectively treated by one operation in specialist centres.
However only 24% of clinicians who submitted samples suspected that this was the case, as most hypersomatotropism cats did not display typical signs, instead displaying symptoms indistinguishable from cats with primary (type 2) Diabetes Mellitus. This suggests that hypersomatotropism screening should be considered when treating diabetic cats.
Lead researcher, Dr Stijn Niessen from the Royal Veterinary College, said: "It has been common practice to automatically suspect a cat with Diabetes Mellitus to be suffering from a form of diabetes akin to human type 2. The current study suggests that this is an oversimplification. Approximately one in four of assessed diabetic cats were actually found to be suffering from hypersomatotropism-induced Diabetes Mellitus, which requires specific treatment and manifests itself very differently as it develops.
"Interestingly, only a small proportion of clinicians reported they strongly suspected acromegaly to be present on the basis of the clinical picture. These data therefore highlight the need for veterinarians working with the spontaneously diabetic cat to consider routinely screening for the presence of hypersomatotropism-induced Diabetes Mellitus, given the significant clinical consequences of its presence.
"Should the hypersomatotropism be diagnosed and treated with one operation, most cats will enter a state of diabetic remission. If it remains undiagnosed, diabetic cats tend to be difficult to regulate glycaemically which often results in euthanasia, or in the long-term, they will suffer from other growth hormone-induced negative conditions such as heart disease, as well as central nervous system problems."
Evaluation of serum fructosamine was offered free of charge for all diabetic cats attending any veterinary practice in the UK from October 2003 till April 2011. Veterinary surgeons were asked to record clinical data about the patient, including age, breed, gender, current body weight, current administered insulin dose and whether they clinically suspected acromegaly/ hypersomatotropism. Diabetic cats were screened using serum total insulin-like growth factor-1, followed by further evaluation through pituitary imaging and/ or histopathology.
In total, 1221 diabetic cats were screened; 319 (26.1%) had a blood IGF-1 suggestive of hypersomatotropism. Of these cats a subset of 63 (20%) underwent pituitary imaging and 56/63 (89%) had a pituitary tumour on computed tomography; an additional three on magnetic resonance imaging and one on necropsy. These data suggest a positive predictive value of serum IGF-1 for hypersomatotropism of 95%, suggesting the overall hypersomatotropism prevalence among UK diabetic cats to be 24.8%.
The paper also suggests that although great opportunities exist for comparative research between primary (type 2) diabetes in cats and humans, researchers should exercise caution in light of these new findings.
Stijn added: "The similarities between feline and human type 2 diabetes emphasise great opportunities for valuable comparative research benefiting all species into this major disease, which is fast becoming a global epidemic. However our latest research proves that there is a need for more regular hypersomatotropism screening, to identify the root cause of diabetes in domestic cats before samples are used, so as not to corrupt results."
Prilactone Next is replacing the spironolactone products Prilactone and Tempora, which will be discontinued.
Prilactone Next is available in three presentations of 10mg, 50mg and 100mg. It comes in easy-break, chewable tablets, designed to make it easier to give the required dose. The 10mg tablet has a two-way split for a dog between 2.5kg and 5kg, while the 50mg and 100mg tablets have a four-way patented clover-shaped design with the 50mg for dogs between 18.1kg and 25kg and 100mg for dogs between 37.6kg and 50kg.
Prilactone Next is available in boxes of three blisters of 10 tablets for the 10mg and 50mg presentations and three blisters of eight tablets for the 100mg presentation, for easy dispensing and storage in practice.
Nicola Barclay, product manager at Ceva Animal Health, said: "Prilactone Next is an improved, easy to administer spironolactone that enables owners to accurately treat their pets and will further enhance our existing cardiology range."
For further information, contact your local Ceva Animal Health territory manager.
The flowchart, which was produced in partnership with the National Animal Health and Welfare Panel (NAHWP) and with support from Dogs Trust, outlines what vets should consider when a client presents an animal with a pet passport and aim to help them navigate client confidentiality, how to report concerns of illegal imports, and an overview of how local authorities are likely to respond.
The Association says that in recent years, vets have mentioned finding it 'difficult' or 'very difficult' to report concerns to Trading Standards in the BVA Voice of the Veterinary Profession surveys. Other concerns included breaching client confidentiality, a lack of proof or sufficient evidence to investigate, a perceived lack of interest from local authorities if a case was reported, and uncertainty about whom to contact and how to report suspicions.
Findings released by Dogs Trust earlier this week show broadly similar concerns about reporting suspected illegal pet import cases.
BVA and NAHWP have issued the following advice for vets:
Report any suspicions that the animal in your care does not comply with Pet Travel Scheme requirements to your Local Authority Animal Health Function – either Trading Standards or Environmental Health Services.
Find out how to contact your local authority via a pre-agreed number for your practice. Find a direct contact number for your local Trading Standards or call Citizens Advice Consumer Helpline on 03454 04 05 06, who will refer you directly to the relevant local authority.
Note this number down on the joint BVA and NAHWP compliance flowchart and put up the poster in visible locations around your practice for staff to refer to.
BVA is also in talks with local authority forums in Wales and Scotland and the Department of Agriculture, Environment and Rural Affairs in Northern Ireland to launch similar guidance and compliance resources for vets in the devolved administrations.
BVA President Daniella Dos Santos said: "Veterinary teams can often be the first to suspect that an animal may have been illegally imported when an owner takes their pet for its first check-up. But our surveys have identified a compelling need for clearly defined routes and mechanisms for vets to more easily report suspected cases of illegal import.
"Our flow chart and supporting guidance aim to empower vets to report any such cases, thus helping to tackle the scourge of illegal importation and protecting animal welfare, both of the imported dogs and the larger canine population in the UK.
"I would encourage veterinary teams to put up the poster in their practices and use it to help report any suspicions to relevant authorities with ease."
The flowchart is available as a pull-out poster in this week’s Vet Record and can also be downloaded along with accompanying guidance notes here: www.bva.co.uk/illegalimportguidance
Renutend contains primed mesenchymal stem cells (MSCs) which Boehringer says are specifically targeted to reduce scar tissue formation so horses can return to the intended level of performance, with a reduced risk of re-injury1.
According to the company, a single dose decreases scar tissue formation with consistent and proven results 2.
RenuTend is administered by intralesional injection and complements Boehringer Ingelheim’s other equine stem cell product Arti-Cell Forte, which is authorised to treat mild to moderate recurrent lameness associated with non-septic joint inflammation in horses.
RenuTend will be available in September this year.
In the meantime, Boehringer is encouraging veterinary surgeons to register their interest with their BIAH representative or call 01344746960 in order to get updates or product information as soon as it becomes available.
References
The range includes:
Fluodrop (the first fluorescein product specifically designed for veterinary use)
Ocryl - an ocular and periocular cleanser that can also be used to reduce and prevent unsightly tear staining
Ocular lubricants (carbomer and hyaluronic acid based)
Clerapliq – a novel molecule to the UK veterinary market that is used to help restore and regenerate the corneal extracellular matrix
The products will be supported with a selection of materials to help vets, nurses and pet owners in the maintenance of corneal health, including diagnosis and treatment guidelines, anatomical guides, posters and client educational and treatment aids to help with compliance.
William Peel MRCVS, product manager at TVM-UK said: "Our Corneal Focus Range is an exciting way to expand on our product portfolio following the successful introduction of our ‘Anti-tox’ range.
"With ‘Anti-tox’ we successfully managed to make vets and nurses lives easier by providing education and materials alongside a great range of products to help when dealing with poisoning cases in practice. We also attempted to make clients more aware of the dangers of poisoning in pets.
"We hope to emulate this approach and success with our Corneal Focus Range – by developing a wealth of materials for vets, nurses and clients to aid them in managing and understanding ophthalmology cases – and by providing quality products."
TVM UK will be showcasing its new products and support services at the London Vet Show (stand P40) this November.
For more information, visit: http://www.tvm-uk.com/
The Vital Support launch includes a new Feline Renal Multipack to support cats with chronic kidney disease and loss of appetite. The multipack contains four wet pouches with different aromatic profiles to help stimulate decreased appetite and deliver optimum food acceptance and compliance. Multipacks will be available from October 2020.
Royal Canin has also introduced new Early Renal diets to help support the kidneys at early stages of renal insufficiency, and will be discontinuing its Feline VCN Senior Consult Stage 2 diets.
The company is also introducing two new diets for small dogs: Renal Small Dogs to support small breed dogs in the more advanced stages of chronic renal insufficiency, and Mobility C2P+ Small Dogs, formulated to support healthy joint function.
Other changes include a switch to 100% sustainably sourced salmon in its renal wet pouches, and to vegetable sources of glucosamine, instead of shellfish.
For more information, visit: https://vetportal.royalcanin.co.uk, speak to a member of the veterinary pillar team or contact the Nutritional Helpline.
Tialin is licensed for the treatment of dysentery, colitis, ileitis, pneumonia and pleuropneumonia in pigs. It is also suitable for the treatment and metaphylaxis of chronic respiratory disease and infectious synovitis in chickens and infectious sinusitis and airsacculitis in turkeys. Withdrawal times range from zero in eggs to two - six days in meat and offal.
The product is available in two strengths: 25% (250 mg/ml) and 12.5% (125 mg/ml). It can be bought in five and one litre bottles with a shelf life of two years or three months once opened.
Dechra Brand Manager Emma Jennings said: "Any of these diseases could have a widespread effect on a herd or flock of any size so it is vital that veterinary professionals have access to a treatment such as Tialin to offer farmers.
"Its short withdrawal times and long shelf life makes it a cost effective and valuable tool for vets and farmers in their treatments of these diseases. All the products in our premium SoluStab range have been specifically developed with a unique formula to provide the optimum balance of stability and solubility."
For more information, visit www.dechra.co.uk/therapy-areas/food-producing-animal/water-medication.
Dechra also offers an online tool to calculate dosage for SoluStab products at http://calculator.solustab.eu/.
The survey was promoted to the profession via the websites, by Veterinary Times and through the RCVS Mind Matters newsletter. The data was then anonymised, analysed and reported on by Sally Everitt MRCVS, ex Head of Scientific Policy at BSAVA.
677 participants reported being on the receiving end - within the last year - of at least one of 15 types of unpleasant behaviour which ranged from being physically intimidated through to being on the receiving end of sly glances. However, on average, each respondent experienced no less than five different types of unpleasant behaviour.
Of these, 390 were veterinary nurses, 252 were veterinary surgeons and 13 were practice managers.
The most frequently reported behaviours were: 'being belittled in front of other staff' (73%), 'being criticised minutely, repeatedly and seemingly unfairly' (65%), 'being aware of management or senior staff talking negatively about you behind your back' (51%), and '‘having your authority undermined to others in the practice, for example by having your instructions countermanded commonly and without consultation' (50%).
Seen in isolation, some might question whether these sorts of behaviour amount to bullying. It is important therefore to stress both that they typically formed part of a pattern of behaviour (the five different behaviour types reported, on average, by each respondent), and that the survey specifically asked only for reports where the behaviour was repeated.
Separately, 344 people also said they were currently on the receiving end of sustained patterns of behaviour, usually from one person, which seemed designed to make their life unpleasant.
Respondents were also invited to describe in more detail how they felt they had been mistreated at their practice.
Sally said: "Reading the responses, four main themes stood out: not feeling part of the team, lack of respect, lack of support and issues around management including not being listened to and perceptions of being treated unfairly."
Participants in the survey were then asked to describe what impact the behaviour had on their working life.
Sally said: "The answers to this question often demonstrated that the respondents had been very upset by the behaviours. Of the 560 replies to this question, 220 described an impact on their mental health, from anxiety to breakdowns and suicidal thoughts. 120 respondents talked specifically about the impact on their lack or loss of confidence, and 207 talked about leaving their job or the profession entirely."
Survey participants were then asked what they planned to do about it. Out of 680 replies, 195 talked about moving practice as soon as they can, 164 said they would take it up with the practice manager (however, of the 55 who reported this in the free text answer, 30 said it led to no change or made things worse), and 109 said they had no choice but to suffer in silence. 45 said they had or would leave the profession and only 35 said they would take it up with the perpetrator themselves.
As regards who is bullying who, more or less the same number of people reported being bullied by a veterinary surgeon as a veterinary nurse. What was interesting, and important for those in positions of leadership to note, is that veterinary nurses were much more likely to be bullied by other nurses and vets by other vets.
Finally, respondents were asked a series of questions about whether there was a zero tolerance of bullying or conflict resolution policy in force and enforced at their practice. Only 24 and 28% of respondents respectively were aware of such policies being in place. What was also clear was that having such policies and enforcing them correlated with lower levels of being on the receiving end of sustained patterns of unpleasant behaviour at the practice.
Arlo Guthrie, Editor of VetSurgeon.org and VetNurse.co.uk said: “Above all else, I want to thank everyone who shared their experience so that others can draw comfort in knowing they are by no means alone in this. I also want you to know that you’ve been heard.
"Given the survey design, it is not possible to draw any conclusions concerning the prevalence of bullying in the veterinary profession. What we can say for sure is that there have been 680 reports. If, as the data indicates, these are from different practices, then it is something that goes on in a significant proportion of veterinary practices."
"The million dollar question is what needs to be done next. It seems to me that the first and most important thing is that the profession needs to talk about behaviour and its impact openly and candidly, mirroring the great strides forward in the area of mental health."
In addition, the survey report proposes further discussion - at both a practice and professional organisation level - about things which:
As one veterinary nurse commented: "Pay is obviously important when you have a mortgage and bills, but not dreading going into work every day, it’s priceless!"
To download the report in full, click the link below:
PDF
Betafuse contains 5mg/g fusidic acid and 1mg/g betamethasone gel. It is available in 15g and 30g polyfoil tubes, designed to reduce the likelihood of splitting and loss of product during use.
Richard Palmer, Global Head of Sales and Marketing at Norbrook said: "We are delighted to be bringing this new product to the market in 16 European countries including the UK and Ireland. Betafuse is particularly exciting for us as we have improved the packaging and we have extended the 'in use' shelf life to eight weeks in comparison to six weeks for the pharmaceutically equivalent pioneer.
"This continued investment in our companion animal portfolio comes on the back of our recent launch in the US of Carprofen Chewable Tablets, an anti-inflammatory also for dogs. Our £40 million multi-year investment programme which we are currently engaged in, includes a significant emphasis on new product development including investment in R&D and our facilities infrastructure."
Lizzie Barnard, UK Product Manager added: "Betafuse offers the prescribing veterinary surgeon greater choice and it complements our existing companion animal skin care portfolio which includes Marbodex, a treatment for otitis externa in dogs.
"“Product support material is available and includes a guide for dog owners on how to apply Betafuse simply and effectively. This leaflet is available by contacting your territory manager or by downloading it from our website."
For more information, visit: https://www.norbrook.com/
European Specialist in Veterinary Dentistry Lisa Milella has revealed in an interview with the Sunday People that she has been diagnosed with motor neurone disease, a condition which few people survive for more than 2-5 years.
It's hard to imagine anything much worse than being told in advance when your appointment with the Grim Reaper is booked, and for many the temptation might be just to give up there and then. Not Lisa. She embarked on the most extraordinary mission to fulfill ten of her life's ambitions.
The day after her diagnosis last August, she closed her veterinary practice in Byfleet. In December, she went sledging with huskies in Norway. In January, she flew to Borneo to carry out dental surgery on an orangutan. Three days later, she visited International Animal Rescue in Java and trained vets there to carry out dental work on slow lorises. She then celebrated her 40th birthday surrounded by friends and family in February. In May, she headed out to Peru to visit the Inca trail and the Amazon rainforest. From there, it was on to the Galapagos Islands. Then last week she went to India, where she trained another team to perform dental surgery on bears, and fulfil the 8th and 9th ambitions on her list, which were to operate on a leopard and a tiger.
Lisa closed her interview in the Sunday People saying: "I'm never going to get better and today is as strong as I'm ever going to be. You've got to make the most of now and not worry about tomorrow. Go out there and do it. You're never going to have that time again."
Oh. One other thing. Lisa's 10th wish was to get 100 strangers to donate £100 to International Animal Rescue. I hope you'll join me: https://www.justgiving.com/Lisa-Milella-100/
With fewer than 72 female Suffolk Punches remaining in the UK and fewer than 300 in the world, every female born is vital to the survival of this endangered British horse.
In 2019 Tullis Matson, owner and managing director of Stallion AI Services, saw an opportunity to use a new technological advancement in the sex sorting of equine semen to provide a lifeline to Britain’s critically endangered rare and native horses.
Tullis said: “To be able to use our reproduction expertise in this way, to help preserve an irreplaceable part of our magnificent heavy horse heritage is something we have been working towards for many years. The challenges have been great and many, but watching the birth of this beautiful, healthy filly foal was a truly magical experience."
The sex sorting project uses specialist equipment to sex sort the semen prior to insemination based on the difference in DNA content between X and Y bearing spermatozoa.
Ruby, the Suffolk Punch mare and Holbeach Iggy, the Suffolk stallion were selected and matched based on their genetics as part of a project between The Rare Breed Survival Trust and Nottingham Trent University that uses pedigree information to enable the breeding of small populations in a way that minimises the risk of inbreeding and genetic decline.
Christopher Price, Chief Executive of the Rare Breed Survival Trust, said: “This is tremendous news for anyone concerned with the conservation of our native equines. The most effective way of increasing the population size of this very rare breed is by increasing the number of fillies being born.
“The project demonstrates the viability of using new techniques for selecting female foals in order to increase the breeding population much more rapidly than could be achieved through relying on traditional methods. We hope it will prove to be a model for more projects in the future.”
Researchers studied 840 patients with breast, prostate, lung or colorectal cancer. 280 patients that had received only alternative medicine were matched to 560 control patients who chose conventional cancer therapy.
Overall, cancer patients who used alternative medicine were 2.5 times more likely to die within a 5 year period than those who chose conventional cancer therapy.
However, people with breast cancer were 5.7 times more likely to die in the same period if they used alternative medicine rather than conventional medicine.
This evidence flies in the face of the British Association of Veterinary Homeopathic Veterinary Surgeons' claim that homeopathy cures cancer.
But more importantly, one of the main reasons why practitioners in both human and veterinary medicine so often acquiesce to their patients' use of alternative medicine is because of the perception that they do no harm. After all, homeopathy is only water, right?
This study provides perhaps the first evidence that the reverse may be true. That if you do not actively deter clients from using discredited forms of alternative medicine, you may be allowing them to sentence themselves, or rather their dog, to an early death.
According to the company, two promotional videos it prepared for social media have already reached more than 1.7 million people in the first two days of the campaign.
Virbac says that some of the UK's best loved pet influencers will also be promoting the campaign to their followers over the coming week.
What is a pet influencer, anyway? Someone who influences pets? I picture a Barbara-Woodhouse sort of character surrounded by a rapt audience of dogs: "Come on now, dogs, eat Veterinary HPM, it really is properly yummy, and sooo good for you."
I digress.
As part of the campaign pet owners will be able use an online protein calculator to check whether their current pet food is providing optimal levels of protein to their pet.
Pet owners will also be able to locate their nearest veterinary practice stockist using a new locator tool on the Virbac website and benefit from a discount voucher for their first Veterinary HPM purchase, which can only be redeemed in participating veterinary practices.
Tracey West, Nutrition Manager at Virbac, said: "Nutrition plays such a key role in the long-term health and well-being of our pets, and veterinary practices play such a key role in educating pet owners on this important subject.
"We’re delighted that as part of our ‘pro-veterinary’ strategy for Veterinary HPM, we will be able to help drive pet owners back into veterinary practices with this campaign."
For more information, speak to your Virbac Territory Manager.
MSD Animal Health has launched an improved on-farm calf-side scour pathogen testing kit for faster diagnosis of the main infectious organisms implicated in a disease outbreak.
According to the company, the new ScourCheck Rapid Programme promises a 10-minute diagnostic turnaround from faecal sample to result, enabling the veterinary practitioner to offer more timely disease management recommendations without having to wait for a laboratory report. The new kits deliver on-farm identification of rotavirus, coronavirus, cryptosporidium and E. coli K99.
Further details on the ScourCheck Rapid Programme are available from MSD Animal Health account managers.
The company says Salmoporc has been used on German and Polish farms for over 15 years and has proved to be safe and effective in controlling salmonella.
The vaccine can be administered orally in piglets and via subcutaneous injection in sows.
Company vet Dr Rike Schmelz said: "Salmonella in pigs is growing threat and an important zoonotic disease. According to the 2018 European Food Safety Authority (EFSA) report, salmonellosis is the second most reported zoonosis in Europe with over 90,000 cases reported in humans.
"Salmonella typhimurium and monophasic Salmonella typhimurium represented 17 per cent of confirmed human cases in 2017 so constitutes a major risk to humans."
VetSurgeon.org understands the new vaccine is expected in the UK sometime after October, before which it can be obtained under a Special Import Certificate.
ISFM points to an editorial published ten years ago in The Lancet (Hypertension: uncontrolled and conquering the world), which presented alarming facts about hypertension in people: the risk of becoming hypertensive during a lifetime exceeds 90% for people in developed countries, with over 1.5 billion adults expected to have hypertension by 2025. It also said: 'screening is not done systematically, and the diagnosis is often made at a late stage when target organ damage has already happened'.
The Society says there are broadly similar concerns in our feline companions. Hypertension is a well-recognised condition in older cats, yet probably remains significantly underdiagnosed. The consequences can be severe, with target organ damage typically affecting the eyes, heart, brain and kidneys. Some damage, such as blindness resulting from complete retinal detachment, is irreversible. Other damage, however, is more amenable to antihypertensive treatment, highlighting the importance of early diagnosis and intervention. However, this presents challenges, particularly as routine blood pressure monitoring is generally performed infrequently in cats. Furthermore, cats are notoriously susceptible to stress in the veterinary clinic, which can lead to 'white coat hypertension' and hamper interpretation of results.
The new ISFM consensus guidelines are published in its Journal of Feline Medicine and Surgery1. The recommendations are those of an expert panel of veterinary clinicians and academics gathered from the UK, Australia, New Zealand, Spain, France and the USA, and cover several key areas. They include: how often to monitor blood pressure for cats of different ages and health status; when antihypertensive therapy is justified based on different systolic blood pressure readings and evidence of target organ damage; and what an investigation of hypertensive cats should include.
Samantha Taylor, a specialist in feline medicine and one of the co-chairs of the guidelines panel, said: "Well-illustrated and easy to read, it is hoped that these guidelines will encourage more widespread monitoring of blood pressure in veterinary clinics to increase the early identification of this treatable condition, and prevent the severe clinical consequences of untreated hypertension."
Accompanying the guidelines, which are endorsed by the American Association of Feline Practitioners, are further resources to assist veterinarians with the diagnosis of hypertension. A blood pressure evaluation form can be downloaded from the supplementary material; in addition, a series of short videos produced by the ISFM on measuring blood pressure in cats is available in various languages at https://www.youtube.com/user/iCatCare/playlists.
The idea for an interactive vaccination calendar was in fact first developed two years ago by Jon Reader MRCVS (pictured right) from Synergy Farm Health. With input and funding from Boehringer, it has now been developed into an online tool which highlights times when animals may be at risk if immunity has waned, without sufficient boosting of immunity by vaccination.
The transmission of BVD is complex and protecting the foetus from the virus is at the heart of any control programme. The virus is passed from dam to foetus and, if this occurs in the first third of pregnancy and the foetus goes to term, a persistently infected (PI) calf will be born. These will then go on to shed virus throughout their lives, so infecting herdmates and the next generation of calves.
Jon said: "The timing of when a vaccine is given is critical to the development of an immune response, which will protect the unborn foetus.
"Working out when you want the dam to calve and then calculating back shows when either a primary course of BVD vaccine or a booster should be given but, get this wrong and you will end up with what is known as an 'immunity gap'.
"It is vital that both heifers and cows have maximum protection during the breeding period and in early pregnancy."
Boehringer says heifers must be fully protected before being served for the first time, and cows must have had immunity boosted before they are pregnant again. However, far too often heifers are adequately protected following an initial booster but given their age and date of service, do not receive further protection until they enter the adult herd.
Jon said: "If heifers calve just after the herd booster, then there is a very real possibility that they will go for two years without a booster, and be severely exposed when they become pregnant as a first lactation heifer."
"This is termed the immunity gap; a period when the animal is not protected from the virus at all. The aim should be to eliminate this period completely, so that there is no immunity gap."
Matt Yarnall from Boehringer said: "Each BVD vaccine has its own timing protocol stating when the primary course should be given, as well as subsequent booster timing and when cows should be served. Moreover, some of these are not straightforward to follow, especially for year-round calving herds."
"Anyone using the Bovela vaccine has peace of mind that the one dose primary course combined with flexible booster regime and 12 months’ proven duration of immunity minimises the immunity gap."
For more information, visit: makebvdhistory.co.uk.
In the past, few employers in the veterinary profession have chosen to advertise salary details, perhaps because they don't want to open a negotiation with their cards on the table, or perhaps they've been fearful of their existing employees finding out what they're prepared to offer a new candidate.
In the VetSurgeon forums, some employers have also remarked that the job isn't about money, and they wouldn't be interested in a candidate whose search criteria included the salary on offer.
The reality, of course, is that we all have bills to pay, children to feed or mortgages to cover and whilst few if any veterinary surgeons search for a job on the basis of salary alone, it's perfectly reasonable that the salary is part of their deliberations.
More than that, all the indications are that job advertisements which include salary details generate more, better qualified responses. Reed carried out a survey of 1000 jobseekers in 2016, 2/3rds of whom said they would be more likely to apply when a salary is displayed on the advert. Another company, Smart Recruit Online, found back in 2013 that job adverts which included a salary generated 30% more responses that those that didn't.
There are also indications that in the future, Google may start to prioritise jobs advertised with salary information in its search results.
To try and strike a balance between some employers' reluctance to display what they might be prepared to pay and the need for greater transparency, advertisers can now display a 'Minimum Offer' on VetSurgeon Jobs, described to the potential applicant as: "The minimum this employer is prepared to offer someone with the skills and experience needed to fulfil the job requirements. They may or may not be prepared to offer more. They may also be prepared to accept someone with a lower level of qualification or experience for an amount less than displayed."
Alternatively, employers can advertise a 'Pay Range', described to potential applicants as: "The employer expects to pay something within the displayed range, depending on their assessment of the value of the applicant's skills and experience to the practice."
In addition, employers can also display other benefits which are likely to be of more or less value to individual applicants, such as a RCVS fees, association subscriptions, health insurance and CPD allowances.
VetSurgeon.org Editor Arlo Guthrie said: "This is entirely optional, but I do hope as many employers as possible will make good use of this new feature, because all the research and anecdotal evidence suggests it’s what candidates want to hear, and it should lead to a better response. Not to mention how time-saving it is for two people to come to the table with realistic expectations."
The company says it is calling for the change after analysing the records of its consultations held during the pandemic and finding that there was a low antibiotic prescribing rate, treatments were effective and no harm was caused.
During the seven months that Vet-AI collected data, from the 1st April to the 31st October 2020, its vets held 21,383 veterinary video consultations, an analysis of which is the subject of a paper published in the RCVS Knowledge journal, Veterinary Evidence1.
78.1% of the consultations were for dogs and 21.9% for cats.
Of the vet-led video consultations completed, 3,541 had medicines prescribed during the consultation.
Some consultations required more than one prescription, which meant a total of 4,282 POM-V medications were prescribed.
Of those, Vet-AI says 0.87% reported a mild adverse effect.
Antibiotics were prescribed in 5.9% of all consultations, 99.3% of which was first line.
Vet AI says follow-up on prescribing was available in 67.7% of cases and 89.4% of all known treatment outcomes were complete or had an expected response to treatment.
Skin problems were the most common body system/disease category seen and prescribed for.
The remaining 17,482 consultations, which did not require a prescription medicine, had resolutions assigned.
They included 959 referrals to an emergency in-person veterinarian visit; 4,852 recommendations to visit a vet in-person; 4,216 alternative products recommended, 6,421 follow-up consultations with the remote veterinary team, and 219 remote laboratory tests.
Samantha Webster MRCVS (pictured right), from Joii Pet Care, said: “Given the clear evidence outlined in this report, we believe the future of veterinary medicine should include remote consultations with remote prescribing where appropriate and regulated.
"We invite the RCVS and other veterinary governing bodies to consider that there is a place for prescribing remotely on an ongoing basis for certain cases under certain conditions, such as a secure video and audio link with clinical record keeping and pharmacovigilance practice.
"A blanket ban is not appropriate with the advance of modern technology."
“Bold steps have been taken in human health, incorporating modern technologies to support both GPs and patients, to great success.
"Our industry could use these learnings to help reduce the current strain and demands on vets across the country where mental health is already a key issue due to increased pressures, under resourcing, and compassion fatigue.
“We feel it’s important to take this approach to reach as many owners and provide professional advice and appropriate treatment on pet health so that those animals that do not necessarily currently receive veterinary care do so, and to bridge the gap wanted by clients.”
Sam and Dick will be joint Clinical Directors of the hospital and co-owners of the business alongside the Pets at Home Vet Group, their Shared Venture Partner.
They say the vision is to create a world-class facility with a team of highly motivated veterinary specialists, nurses and support colleagues providing outstanding levels of service to meet the needs of referring veterinary surgeons, their clients and patients.
The purpose-built facility will offer specialist referral services across a range of disciplines, including anaesthesia, diagnostic imaging, internal medicine, orthopaedics, neurology and soft tissue surgery. Emergency referrals will be accepted seven days a week, 24 hours a day.
Sam said: "It is truly exciting to build a new team of experienced specialists who have clinical excellence as their priority. We also relish the chance to develop great relationships with professional colleagues in first opinion practices. This will allow our hospital to deliver an exceptional level of service for referring veterinary surgeons and their patients."
Dick said: “This is a very exciting step and I am delighted to be instrumental in ensuring that our new centre in Scotland offers the very best in veterinary care”.
The hospital will be based at Deer Park in Livingston, with convenient parking and easy access to the M8 and other major road and rail networks. In addition to clinical services, it will provide a CPD programme, including internship and residency opportunities.